- Adverse Event (AE16)
- Additional Measures (AM2)
- Baseline Randomization (BR2)
- Confirmation Visit (CF10)
- Contact Verification (CV1)
- Decline to Participate (DC2)
- Decline to Participate-Genetics (DG16)
- Diabetes History (DH16)
- Death (DT3)
- Endpoint (EN12)
- Follow-up Visit (FV21)
- Genetics Consent (GC3)
- IOP Determination (IP2)
- Lens Opacities Classification (LC3)
- Missed Visit (MV6)
- Medical Withdrawal (MW2)
- Protocol Exemption (PE3)
- Pachymetry (PY16)
- Qualifying Assessment (QA5)
- Quality of Life (QL16)
- Randomization Phone Call (RA2)
- Symptom Checklist (SY6)
- Treatment Change (TC11)
- Transition Visit Status (TV1)
- Unscheduled Visit (UN16)
- NEI VFQ (VQ16)